Veradigm (NASDAQ:MDRX) Shares Down 5% – Should You Sell?

Veradigm Inc. (NASDAQ:MDRX – Get Free Report) shares dropped 5% on Monday. The stock traded as low as $4.75 and last traded at $4.75. 5,346 shares were traded during trading, a decline of 95% from the average session volume of 115,586 shares. The stock had previously closed at $5.00.

Veradigm Stock Performance

The company has a market capitalization of $580.92 million, a P/E ratio of 23.25 and a beta of 0.51. The business’s fifty day simple moving average is $4.89 and its 200-day simple moving average is $4.81.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc is a healthcare technology company that develops software, data, and analytics solutions for healthcare providers, payers, and life sciences organizations. Its products are designed to support clinical workflows, electronic health records, practice management, revenue cycle operations, electronic prescribing, and healthcare data exchange.

The company also provides healthcare data and analytics tools intended to help organizations improve clinical decision-making, coordinate care, manage populations, and evaluate treatment and operational outcomes.

Further Reading

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.